NCT04837430 is a clinical trial in Dengue Shock Syndrome, sponsored by Le Phuoc Truyen.

Who is sponsoring NCT04837430?

NCT04837430 is sponsored by Le Phuoc Truyen.

What condition does NCT04837430 study?

NCT04837430 studies Dengue Shock Syndrome, Children, Only.

Is NCT04837430 still recruiting?

NCT04837430 is currently status unknown. Last updated 22 September 2023.

Last reviewed 2023-09-22 · How we verify

NCT04837430

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

NT-proBNP and Troponin I in Dengue Children

Status unknown Last updated 22 September 2023

What this trial tests

trial in Dengue Shock Syndrome in 90 participants. Status unknown.

Timeline

2 April 2021

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	Le Phuoc Truyen
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	90
Start date	2 April 2021
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	1 location across Vietnam

Conditions studied

Dengue Shock Syndrome — all drugs for Dengue Shock Syndrome →
Children, Only — all drugs for Children, Only →

Sponsor

Le Phuoc Truyen

Who can join

Adults 1 Month to 18, any sex, with Dengue Shock Syndrome or Children, Only. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To discribe concentration of NT-proBNP and Troponin I in Dengue hemorrhagic shock children, in correlation between concentration of NT-proBNP and troponin I with total fluid admission, respiratory support, using inotrope and vasopressor using.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Inhibitory Potential of Chromene Derivatives on Structural and Non-Structural Proteins of Dengue Virus.
Dharmapalan BT, Biswas R, Sankaran S, Venkidasamy B, et al · · 2022 · cited 7× · PMID 36560664 · DOI 10.3390/v14122656

Verify or expand the search:

Other recruiting trials for Dengue Shock Syndrome

Currently open trials in the same condition.

NCT06642493 — Efficacy of Fresh Frozen Plasma (FFP) in Treating Thrombocytopenia in Dengue Patients · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04837430 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Le Phuoc Truyen
Last refreshed: 22 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04837430.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing